Elmar Kraus is ranked #2117 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Elmar Kraus

Q: How accurate are Elmar Kraus's stock ratings?

About 52% of Elmar's ratings were profitable over a one-year hold, with an average return of +2.6% per rating, measured by 13Foresight from historical prices.

DZ BANK AG

Wall Street Analyst

★★★☆☆

#2117

on 13Foresight · ranked by our own returns

52%

Success Rate

+2.6%

Average Return

15 of 29 calls profitable · -8.7% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 52% of Elmar Kraus's ratings turned a profit when each position was held for 1 year — averaging +2.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

13 Buy 13 Hold 0 Sell

Elmar's Stock Coverage 25 ratings · 2026-08-12

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
GB:0QIU Novo Nordisk	Aug 07, 2026	HOLD	Hold +33.5% avg upside 29 analysts	—	·	·
PFE Pfizer	Aug 06, 2026	BUY	Buy +25.8% avg upside 45 analysts	—	+3.2%	·
FR:SAN Sanofi	Jul 31, 2026	BUY	Strong Buy +30.0% avg upside 30 analysts	—	-0.3%	·
GB:GSK GlaxoSmithKline	Jul 29, 2026	HOLD	Hold +2.1% avg upside 25 analysts	—	-0.2%	·
GB:AZN AstraZeneca	Jul 28, 2026	BUY	Strong Buy +23.4% avg upside 26 analysts	—	-9.8%	·
GB:0QW0 arGEN X	Jul 24, 2026	BUY	Strong Buy -19.2% avg upside 24 analysts	—	·	·
CH:NOVN Novartis AG	Jul 22, 2026	HOLD	Buy -11.3% avg upside 32 analysts	—	-1.9%	·
CH:ROP Roche Holding AG	Feb 02, 2026	BUY	Buy -8.6% avg upside 23 analysts	—	+6.6%	·
ABBV AbbVie	Nov 04, 2025	HOLD	Strong Buy -4.3% avg upside 46 analysts	$237.00 3.59% Downside	+17.9%	·
NL:PHIA Koninklijke Philips N.V.	Jul 29, 2025	HOLD	Buy +29.4% avg upside 21 analysts	—	+1.0%	·
GILD Gilead Sciences	Feb 13, 2025	BUY	Strong Buy -12.1% avg upside 66 analysts	$108.00 18.95% Downside	+50.3%	·
AMGN Amgen	May 07, 2024	BUY	Buy -23.9% avg upside 57 analysts	$343.00 16.50% Downside	-5.3%	·
REGN Regeneron	May 06, 2024	BUY	Strong Buy -2.1% avg upside 58 analysts	$1065.00 35.85% Upside	-41.7%	·
LLY Eli Lilly & Co	May 03, 2024	HOLD	Strong Buy -13.8% avg upside 48 analysts	$800.00 32.54% Downside	+12.8%	·
BMY Bristol-Myers Squibb	Apr 30, 2024	BUY	Buy -4.4% avg upside 42 analysts	$50.00 22.79% Downside	+19.9%	·
MRK Merck & Company	Apr 29, 2024	BUY	Strong Buy -0.7% avg upside 43 analysts	$148.00 15.04% Upside	-33.0%	·
JNJ Johnson & Johnson	Apr 18, 2024	BUY	Strong Buy -9.2% avg upside 39 analysts	$176.00 32.06% Downside	+11.5%	·
BIIB Biogen	Feb 15, 2024	HOLD	Strong Buy +23.5% avg upside 52 analysts	$236.00 13.59% Upside	-38.5%	·
PFS Provident Financial Services	Nov 02, 2023	BUY	Strong Buy +29.0% avg upside 16 analysts	$39.00 59.46% Upside	+32.7%	·
DE:SHL Siemens Healthineers AG	Apr 20, 2022	HOLD	Buy +25.1% avg upside 24 analysts	—	-0.7%	·
GSK GlaxoSmithKline	Feb 11, 2022	HOLD	Hold -14.5% avg upside 19 analysts	—	-15.5%	·
DE:FPE3 Fuchs Petrolub	Aug 24, 2021	BUY	Strong Buy +15.5% avg upside 12 analysts	—	-31.2%	·
MDT Medtronic	May 14, 2020	HOLD	Buy +6.9% avg upside 38 analysts	$92.00 5.63% Upside	+36.5%	·
PHG Koninklijke Philips	Mar 24, 2020	BUY	Buy +34.6% avg upside 13 analysts	$41.90 56.65% Upside	+57.4%	·
NVO Novo Nordisk	May 03, 2018	SELL	Buy +145.4% avg upside 26 analysts	—	-1.2%	·

🔒 20 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Elmar Kraus — Frequently Asked Questions

How accurate are Elmar Kraus's stock ratings?

Based on the calls 13Foresight could measure, about 52% of Elmar's ratings were profitable over a one-year hold, with an average return of +2.6% per rating, or -8.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Elmar ranked on 13Foresight?

Elmar Kraus is currently ranked #2117 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Elmar cover?

Elmar most recently has ratings on GB:0QIU, PFE, FR:SAN, GB:GSK, GB:AZN, GB:0QW0, CH:NOVN, CH:ROP, ABBV, NL:PHIA, GILD, AMGN and 13 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Elmar Kraus

Rating Distribution

Welcome to 13Foresight!